MMI Raises $125M Series D Funding to Expand Symani Surgical System Adoption Worldwide

MMI has announced that it has raised $125 million in Series D financing. The round was led by existing investor BioStar Capital, with participation from new investors S3 Ventures, Angelini Ventures, and an undisclosed strategic corporate investor. Existing investors also contributed. The capital will support MMI's continued commercial expansion in the U.S. and key global markets, while strengthening the foundation needed to expand patient access. There are approximately 50 installed Symani Surgical Systems worldwide, and about 3,500 complex microsurgical procedures have been performed using the system. Investment in clinical trials and outcomes data, including the REMIND study, will also help expand the applications for Symani and support broader adoption. This information comes from the original source and was organized by AI.